URGENT: This Altcoin Opportunity Won’t Wait – Act Now

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

EWTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 24.11%

Insider Buying (Last 12 Months): $5,100,965.10

Insider Selling (Last 12 Months): $11,865,014.27

Edgewise Therapeutics Insider Trading History Chart

Edgewise Therapeutics Share Price & Price History

^$30.78

▼ -0.02 (-0.06%)

As of 12/20/2024 06:16 PM ET

Days: 30 | 90 | 365

AI breakthrough about to upend industry

From Porter & Company | Ad

Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.

I urge you to watch it now.

Edgewise Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/23/2024	John R Moore	General Counsel	Sell	20,922	$27.63	$578,074.86	3,252
9/20/2024	Alan J. Russell	Insider	Sell	75,000	$28.27	$2,120,250.00	12,719
9/20/2024	Joanne M. Donovan	CMO	Sell	7,162	$28.29	$202,612.98	14,538
9/20/2024	John R Moore	General Counsel	Sell	50,000	$28.37	$1,418,500.00	3,252
9/20/2024	R. Michael Carruthers	CFO	Sell	125,092	$28.57	$3,573,878.44	6,904
5/2/2024	Behrad Derakhshan	Insider	Sell	1,718	$18.91	$32,487.38	13,422
5/2/2024	Joanne M. Donovan	CMO	Sell	3,682	$18.91	$69,626.62	19,897
5/2/2024	John R Moore	General Counsel	Sell	1,956	$18.91	$36,987.96	3,252
5/2/2024	Kevin Koch	CEO	Sell	3,152	$18.91	$59,604.32	14,478
5/2/2024	R. Michael Carruthers	CFO	Sell	2,157	$18.91	$40,788.87	35,230
2/9/2024	John R. Moore	General Counsel	Sell	8,029	$20.01	$160,660.29
2/8/2024	Behrad Derakhshan	Insider	Sell	4,600	$20.01	$92,046.00	7,020
2/7/2024	John R. Moore	General Counsel	Sell	17,993	$20.00	$359,860.00
1/23/2024	Peter A. Thompson	Director	Buy	454,545	$11.00	$4,999,995.00	14,436,497
1/23/2024	R. Michael Carruthers	CFO	Sell	90,000	$15.78	$1,420,200.00	29,024
12/27/2023	John R. Moore	General Counsel	Sell	8,497	$10.50	$89,218.50
12/26/2023	Alan J. Russell	Insider	Sell	172,585	$9.33	$1,610,218.05	3,606
12/26/2023	Jonathan C. Fox	Director	Buy	10,857	$9.30	$100,970.10	10,857
5/2/2023	Behrad Derakhshan	Insider	Sell	1,747	$8.90	$15,548.30	7,020
5/2/2023	Joanne M. Donovan	CMO	Sell	3,254	$8.90	$28,960.60	9,960
5/2/2023	John R Moore	General Counsel	Sell	1,897	$8.90	$16,883.30	6,565
5/2/2023	Kevin Koch	CEO	Sell	3,203	$8.90	$28,506.70	7,213
5/2/2023	R. Michael Carruthers	CFO	Sell	1,336	$8.90	$11,890.40	16,126
10/3/2022	John R Moore	General Counsel	Sell	4,730	$9.76	$46,164.80	3,000
9/16/2022	Peter A. Thompson	Director	Buy	484,496	$10.32	$4,999,998.72	13,981,952
9/14/2022	Holdings A/S Novo	Major Shareholder	Buy	484,496	$10.32	$4,999,998.72	6,071,703
8/3/2022	John R Moore	General Counsel	Sell	9,232	$9.31	$85,949.92	3,000
7/5/2022	John R Moore	General Counsel	Sell	8,186	$8.35	$68,353.10	3,000
6/21/2022	John R Moore	General Counsel	Sell	31,078	$7.29	$226,558.62	3,000
6/17/2022	John R Moore	General Counsel	Sell	22,127	$6.62	$146,480.74	3,000
6/14/2022	John R Moore	General Counsel	Sell	3,628	$6.02	$21,840.56	3,000
6/10/2022	John R Moore	General Counsel	Sell	7,125	$6.05	$43,106.25	3,000
6/7/2022	John R Moore	General Counsel	Sell	18,123	$6.61	$119,793.03	3,000
6/3/2022	John R Moore	General Counsel	Sell	15,230	$6.05	$92,141.50	3,000
5/18/2022	Orbimed Advisors Llc	Director	Buy	138,000	$7.21	$994,980.00	13,497,456
5/16/2022	John R Moore	General Counsel	Sell	10,800	$7.42	$80,136.00	3,000

Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis

From Weiss Ratings | Ad

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

SEC Filings (Institutional Ownership Changes) for Edgewise Therapeutics (NASDAQ:EWTX)

Institutional Buying and Selling by Quarter

Edgewise Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/13/2024	Exome Asset Management LLC	59,900	$1.60M	1.1%	N/A	0.063%
11/27/2024	Franklin Resources Inc.	45,223	$1.21M	0.0%	+84.2%	0.048%
11/16/2024	Geode Capital Management LLC	1,599,535	$42.70M	0.0%	-4.4%	1.689%
11/15/2024	Frazier Life Sciences Management L.P.	2,832,867	$75.61M	3.0%	-24.1%	2.992%
11/15/2024	Barclays PLC	119,350	$3.19M	0.0%	+291.0%	0.126%
11/15/2024	Orion Portfolio Solutions LLC	13,011	$0.35M	0.0%	N/A	0.014%
11/15/2024	XTX Topco Ltd	28,303	$0.76M	0.1%	N/A	0.030%
11/15/2024	Wellington Management Group LLP	205,321	$5.48M	0.0%	-58.4%	0.217%
11/15/2024	State Street Corp	1,685,115	$44.98M	0.0%	+1.2%	1.780%
11/15/2024	Quarry LP	3,500	$93K	0.0%	-75.0%	0.004%
11/15/2024	Polar Asset Management Partners Inc.	157,579	$4.21M	0.1%	-16.0%	0.166%
11/15/2024	Parkman Healthcare Partners LLC	657,070	$17.54M	2.2%	+14.4%	0.694%
11/15/2024	Janus Henderson Group PLC	4,558,519	$121.62M	0.1%	+74.8%	4.814%
11/15/2024	HighVista Strategies LLC	88,838	$2.37M	0.8%	N/A	0.094%
11/14/2024	PDT Partners LLC	20,551	$0.55M	0.0%	-21.8%	0.022%
11/14/2024	Fred Alger Management LLC	21,128	$0.56M	0.0%	N/A	0.022%
11/14/2024	Braidwell LP	1,958,310	$52.27M	1.5%	N/A	2.068%
11/14/2024	Walleye Capital LLC	242,251	$6.47M	0.0%	N/A	0.256%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	84,294	$2.25M	0.0%	+5.5%	0.089%
11/14/2024	Ally Bridge Group NY LLC	187,695	$5.01M	2.7%	N/A	0.198%
11/14/2024	Acuta Capital Partners LLC	63,000	$1.68M	1.4%	N/A	0.067%
11/13/2024	Glenmede Trust Co. NA	18,085	$0.48M	0.0%	N/A	0.019%
11/13/2024	FMR LLC	653,208	$17.43M	0.0%	-86.3%	0.690%
11/12/2024	Charles Schwab Investment Management Inc.	522,086	$13.93M	0.0%	-8.6%	0.557%
11/9/2024	Intech Investment Management LLC	19,900	$0.53M	0.0%	N/A	0.021%
11/7/2024	Meeder Asset Management Inc.	3,307	$88K	0.0%	+69.9%	0.004%
11/7/2024	Quest Partners LLC	9,035	$0.24M	0.0%	+418.7%	0.010%
11/1/2024	Quantum Private Wealth LLC	73,424	$1.96M	0.7%	+10.0%	0.078%
10/29/2024	Chicago Partners Investment Group LLC	6,018	$0.16M	0.0%	N/A	0.006%
10/28/2024	US Bancorp DE	8,536	$0.23M	0.0%	+12,452.9%	0.009%
10/25/2024	China Universal Asset Management Co. Ltd.	18,035	$0.48M	0.1%	+64.4%	0.019%
10/25/2024	abrdn plc	256,645	$6.85M	0.0%	N/A	0.275%
10/24/2024	Novo Holdings A S	5,549,900	$148.13M	7.4%	-12.5%	5.942%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	3,392	$88K	0.0%	+21.7%	0.004%
10/23/2024	Moody Aldrich Partners LLC	151,157	$4.03M	0.7%	N/A	0.162%
10/16/2024	Bleakley Financial Group LLC	9,899	$0.26M	0.0%	-35.2%	0.011%
10/3/2024	SG Americas Securities LLC	29,629	$0.79M	0.0%	-53.8%	0.032%
8/20/2024	Novo Holdings A S	6,344,430	$114.26M	5.7%	N/A	6.793%
8/16/2024	Perceptive Advisors LLC	1,856,417	$33.43M	0.8%	-20.0%	1.988%
8/16/2024	Quarry LP	14,000	$0.25M	0.1%	N/A	0.015%
8/16/2024	Frazier Life Sciences Management L.P.	3,731,067	$67.20M	3.1%	+12.9%	3.995%
8/16/2024	Driehaus Capital Management LLC	1,260,392	$22.70M	0.2%	-0.6%	1.349%
8/15/2024	The Manufacturers Life Insurance Company	38,366	$0.69M	0.0%	+25.5%	0.041%
8/15/2024	Millennium Management LLC	1,145,506	$20.63M	0.0%	+115.2%	1.226%
8/15/2024	Dark Forest Capital Management LP	10,699	$0.19M	0.0%	N/A	0.011%
8/14/2024	Squarepoint Ops LLC	52,541	$0.95M	0.0%	+111.4%	0.056%
8/14/2024	Marshall Wace LLP	415,720	$7.49M	0.0%	+661.2%	0.445%
8/14/2024	ProShare Advisors LLC	13,490	$0.24M	0.0%	-20.1%	0.014%
8/14/2024	Profund Advisors LLC	11,405	$0.21M	0.0%	N/A	0.012%
8/10/2024	Sofinnova Investments Inc.	475,691	$8.57M	0.4%	N/A	0.509%
8/9/2024	Dimensional Fund Advisors LP	467,507	$8.42M	0.0%	+56.2%	0.501%
8/8/2024	Federated Hermes Inc.	46,234	$0.83M	0.0%	N/A	0.050%
8/8/2024	Meeder Asset Management Inc.	1,946	$35K	0.0%	N/A	0.002%
8/8/2024	American Century Companies Inc.	860,067	$15.49M	0.0%	+53.8%	0.921%
8/8/2024	State of New Jersey Common Pension Fund D	13,738	$0.25M	0.0%	N/A	0.015%
8/6/2024	Quest Partners LLC	1,742	$31K	0.0%	+156.9%	0.002%
8/5/2024	Arizona State Retirement System	10,459	$0.19M	0.0%	N/A	0.011%
8/1/2024	Rhumbline Advisers	98,269	$1.77M	0.0%	+16.7%	0.105%
7/29/2024	Principal Financial Group Inc.	13,084	$0.24M	0.0%	-22.0%	0.014%
7/26/2024	Bank of New York Mellon Corp	268,712	$4.84M	0.0%	+26.6%	0.288%
7/12/2024	SG Americas Securities LLC	64,173	$1.16M	0.0%	+657.9%	0.069%
7/10/2024	Simplicity Wealth LLC	15,218	$0.27M	0.0%	N/A	0.016%
5/29/2024	Opaleye Management Inc.	665,000	$12.13M	2.6%	-4.9%	0.712%
5/17/2024	RA Capital Management L.P.	8,909,091	$162.50M	2.1%	N/A	9.539%
5/17/2024	Artal Group S.A.	811,718	$14.81M	0.4%	N/A	0.869%
5/16/2024	California State Teachers Retirement System	36,467	$0.67M	0.0%	+23.1%	0.039%
5/16/2024	Janus Henderson Group PLC	1,805,312	$32.90M	0.0%	+48.6%	1.933%
5/16/2024	Kennedy Capital Management LLC	293,265	$5.35M	0.1%	-14.5%	0.314%
5/15/2024	Baker BROS. Advisors LP	5,840,059	$106.52M	1.3%	+87.6%	6.253%
5/15/2024	Price T Rowe Associates Inc. MD	16,424	$0.30M	0.0%	-87.0%	0.018%
5/14/2024	American International Group Inc.	28,418	$0.52M	0.0%	+33.6%	0.030%
5/13/2024	Ameritas Investment Partners Inc.	5,751	$0.11M	0.0%	+37.3%	0.006%
5/10/2024	Vanguard Group Inc.	4,017,433	$73.28M	0.0%	+89.0%	4.315%
5/8/2024	Entropy Technologies LP	12,665	$0.23M	0.0%	N/A	0.014%
5/8/2024	ProShare Advisors LLC	16,885	$0.31M	0.0%	+51.6%	0.018%
5/7/2024	Quantum Private Wealth LLC	66,674	$1.22M	0.5%	+5.5%	0.072%
5/7/2024	Swiss National Bank	67,300	$1.23M	0.0%	+34.3%	0.072%
5/7/2024	SG Americas Securities LLC	8,467	$0.15M	0.0%	-71.6%	0.009%
5/3/2024	GSA Capital Partners LLP	74,511	$1.36M	0.1%	+41.5%	0.080%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	17,321	$0.32M	0.0%	-16.9%	0.019%
4/29/2024	China Universal Asset Management Co. Ltd.	17,881	$0.33M	0.0%	+143.7%	0.019%
4/19/2024	Denali Advisors LLC	19,200	$0.35M	0.1%	N/A	0.021%
2/26/2024	Virtu Financial LLC	24,037	$0.26M	0.0%	N/A	0.038%
2/26/2024	Perceptive Advisors LLC	555,555	$6.08M	0.1%	N/A	0.875%
2/15/2024	Opaleye Management Inc.	699,000	$7.65M	2.0%	-20.2%	1.101%
2/15/2024	Parkman Healthcare Partners LLC	651,625	$7.13M	1.0%	+37.7%	1.027%
2/15/2024	Frazier Life Sciences Management L.P.	2,667,203	$29.18M	1.6%	+214.2%	4.203%
2/14/2024	Pale Fire Capital SE	98,449	$1.08M	0.2%	+529.3%	0.155%
2/14/2024	Sectoral Asset Management Inc.	327,801	$3.59M	1.5%	N/A	0.517%
2/9/2024	Trexquant Investment LP	55,591	$0.61M	0.0%	N/A	0.088%
2/7/2024	Jump Financial LLC	47,100	$0.52M	0.0%	N/A	0.074%
2/6/2024	AJOVista LLC	7,700	$84K	0.1%	N/A	0.012%
2/6/2024	Swiss National Bank	50,100	$0.55M	0.0%	N/A	0.079%
2/1/2024	New York State Common Retirement Fund	70,693	$0.77M	0.0%	+61.1%	0.111%
1/31/2024	abrdn plc	150,418	$1.65M	0.0%	N/A	0.237%
1/30/2024	Quantum Private Wealth LLC	63,219	$0.69M	0.3%	+2.4%	0.100%
1/30/2024	Vontobel Holding Ltd.	327,801	$3.59M	0.0%	N/A	0.517%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	20,833	$0.23M	0.0%	+29.8%	0.033%
1/24/2024	China Universal Asset Management Co. Ltd.	7,338	$80K	0.0%	+349.1%	0.012%
1/12/2024	SG Americas Securities LLC	29,826	$0.33M	0.0%	+59.5%	0.047%

Data available starting January 2016

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.

Today's Range

Now: $30.78

$30.06

$32.61

50 Day Range

MA: $32.81

$27.62

$36.62

52 Week Range

Now: $30.78

$8.64

$38.12

Volume

1,110,575 shs

Average Volume

941,777 shs

Market Capitalization

$2.91 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.12

Who are the company insiders with the largest holdings of Edgewise Therapeutics?: Edgewise Therapeutics' top insider investors include:
Peter A Thompson (Director)
R Michael Carruthers (CFO)
Joanne M Donovan (CMO)
Kevin Koch (CEO)
Behrad Derakhshan (Insider)
Alan J Russell (Insider)
Jonathan C Fox (Director)
John R Moore (General Counsel)
John R Moore (General Counsel)
Learn More about top insider investors at Edgewise Therapeutics.
Who are the major institutional investors of Edgewise Therapeutics?: Edgewise Therapeutics' top institutional investors include:
Novo Holdings A S — 5.94%
Janus Henderson Group PLC — 4.81%
Frazier Life Sciences Management L.P. — 2.99%
Braidwell LP — 2.07%
State Street Corp — 1.78%
Geode Capital Management LLC — 1.69%
Learn More about top institutional investors of Edgewise Therapeutics stock.
Which institutional investors are selling Edgewise Therapeutics stock?: During the last quarter, EWTX stock was sold by these institutional investors:
FMR LLC
Frazier Life Sciences Management L.P.
Novo Holdings A S
Wellington Management Group LLP
Geode Capital Management LLC
Charles Schwab Investment Management Inc.
SG Americas Securities LLC
Polar Asset Management Partners Inc.
During the last year, company insiders that have sold Edgewise Therapeutics company stock include:
Peter A Thompson (Director)
R Michael Carruthers (CFO)
Joanne M Donovan (CMO)
Kevin Koch (CEO)
Behrad Derakhshan (Insider)
Alan J Russell (Insider)
Jonathan C Fox (Director)
Learn More investors selling Edgewise Therapeutics stock.
Which institutional investors are buying Edgewise Therapeutics stock?: In the last quarter, EWTX stock was acquired by institutional investors including:
Braidwell LP
Janus Henderson Group PLC
abrdn plc
Walleye Capital LLC
Ally Bridge Group NY LLC
Jane Street Group LLC
Moody Aldrich Partners LLC
HighVista Strategies LLC
During the previous year, these company insiders have bought Edgewise Therapeutics stock:
Peter A Thompson (Director)
R Michael Carruthers (CFO)
Learn More investors buying Edgewise Therapeutics stock.